David partners with entrepreneurs and innovators in the life sciences, investing in companies across therapeutics, R&D tools, and biopharma infrastructure.
Prior to Lux, David was the co-founder and Head of Strategy & Ops of Latus Bio - a gene therapy company focused on neurological disorders. David additionally spent 4 years at 8VC investing in therapeutics and life sciences infrastructure companies. His passion for biotech first started at the Broad Institute, where he developed computational and experimental tools for viral diagnostics, whose results were published in Nature and Cell.
Ea velit est reprehenderit qui officia nostrud exercitation nisi. Anim pariatur ea voluptate occaecat laborum. Culpa qui sint labore eu aute ut ut. Proident eu ullamco aute commodo qui enim ut. Consectetur esse laborum enim.
Fugiat pariatur quis eu. Esse culpa consequat quis. Qui irure anim nulla deserunt ut est Lorem excepteur dolore occaecat eiusmod velit magna cupidatat. Ex id tempor ea mollit velit aute ex eiusmod sint id incididunt.
“The future is already here... it's just not evenly distributed yet.” — William Gibson